Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL

Acute myeloid leukemia (AML) patients with minimal residual disease and receiving allogeneic hematopoietic stem cell transplantation (HCT) have poor survival. Adoptive administration of dendritic cells (DCs) presenting the Wilms tumor protein 1 (WT1) leukemia-associated antigen can potentially stimu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bialek-Waldmann, Julia K., Domning, Sabine, Esser, Ruth, Glienke, Wolfgang, Mertens, Mira, Aleksandrova, Krasimira, Arseniev, Lubomir, Kumar, Suresh, Schneider, Andreas, Koenig, Johannes, Theobald, Sebastian J., Tsay, Hsin-Chieh, Cornelius, Angela D.A., Bonifacius, Agnes, Eiz-Vesper, Britta, Figueiredo, Constanca, Schaudien, Dirk, Talbot, Steven R., Bleich, Andre, Spineli, Loukia M., von Kaisenberg, Constantin, Clark, Caren, Blasczyk, Rainer, Heuser, Michael, Ganser, Arnold, Köhl, Ulrike, Farzaneh, Farzin, Stripecke, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142053/
https://www.ncbi.nlm.nih.gov/pubmed/34095345
http://dx.doi.org/10.1016/j.omtm.2021.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142053/
https://www.ncbi.nlm.nih.gov/pubmed/34095345
http://dx.doi.org/10.1016/j.omtm.2021.04.004

Ejemplares similares